Medinotec R&D Spending Growth & History (MDNC)
Medinotec's r&d spending was $149,858 for fiscal 2026.
View full Medinotec company overviewMedinotec annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-02-28 | $149,858 | $58,725 | +64.44% |
| 2025 | 2025-02-28 | $91,133 | $68,782 | +307.74% |
| 2024 | 2024-02-29 | $22,351 | −$42,515 | −65.54% |
| 2023 | 2023-02-28 | $64,866 | $30,099 | +86.57% |
| 2022 | 2022-02-28 | $34,767 | — | — |
Medinotec quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-05-31 | $7,970 | −$41,044 | −83.74% |
| Q4 2026 | 2026-02-28 | $26,283 | $21,293 | +426.71% |
| Q3 2026 | 2025-11-30 | $8,326 | −$60,944 | −87.98% |
| Q2 2026 | 2025-08-31 | $66,235 | $64,343 | +3400.79% |
| Q1 2026 | 2025-05-31 | $49,014 | $34,033 | +227.17% |
| Q4 2025 | 2025-02-28 | $4,990 | −$514 | −9.34% |
| Q3 2025 | 2024-11-30 | $69,270 | $66,542 | +2439.22% |
| Q2 2025 | 2024-08-31 | $1,892 | −$9,965 | −84.04% |
| Q1 2025 | 2024-05-31 | $14,981 | $12,719 | +562.29% |
| Q4 2024 | 2024-02-29 | $5,504 | — | — |
| Q3 2024 | 2023-11-30 | $2,728 | −$3,677 | −57.41% |
| Q2 2024 | 2023-08-31 | $11,857 | −$10,035 | −45.84% |
| Q1 2024 | 2023-05-31 | $2,262 | −$31,796 | −93.36% |
| Q3 2023 | 2022-11-30 | $6,405 | — | — |
| Q2 2023 · Sep 30 | 2022-09-30 | $6,405 | −$6,219 | −49.26% |
| Q2 2023 · Aug 31 | 2022-08-31 | $21,892 | — | — |
| Q1 2023 | 2022-05-31 | $34,058 | — | — |
| Q2 2022 | 2021-09-30 | $12,624 | — | — |
Medinotec r&d spending trends
Between the periods ended 2022-02-28 and 2026-02-28, Medinotec's r&d spending increased from $34,767 to $149,858, a change of $115,091. The latest reported quarter, Q1 2027, shows $7,970.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medinotec source filings ↗